Table 6.

Average rank for retained genes in the de novo cross validation for nine disease classes

Disease class	SBN	CSN	Improvement
Nervous system disorder	10.90%	4.50%	59%
Malignant neoplasms	10.20%	4.40%	57%
Cardiovascular disease	10.10%	4.60%	54%
Metabolic disorder	11.30%	5.70%	50%
Mental disorder	18.30%	10.90%	40%
Musculoskeletal and connective tissue disorders	8.10%	5.30%	35%
Digestive system disorders	13.40%	8.90%	34%
Congenital malformations and deformations	8%	5.70%	29%
Skin and subcutaneous tissue diseases	12.70%	9.10%	28%